Graftys
Medical Device, Pharmaceutical Manufacturing, Manufacturing Sector · 11 Employees
Phone Number: stephane.pele@graftys.com
Email Address: stephane.pele@graftys.com
- Overview
- Employees
Access 24 Verified Employees Profiles for GraftysUnlock Free Contacts Now
About
Founded in 2005, Graftys develops, manufactures and markets patented synthetic bone biomaterials, in particular new generations of resorbable calcium-phosphate cements, for reconstructive orthopedic surgery. The Company’s products are commercialized in more than 25 countries, including Europe and the United States of America, through distribution partnership. The objective of the Company is to expand the Company product lines by offering new versions of existing products and new products with enhanced regenerative properties. The Company is based in Belgium (Wallonia) and France (Nantes and Aix-En-Provence).
Website
Year Founded
2005
Social Media
Linkedin
Industry
Medical Device, Pharmaceutical Manufacturing, Manufacturing Sector, Pharmaceutical products, Prostheses, bone substitute, calcium phosphate ceramics based, Health, medical and pharmaceutical, Chemicals, Pharmaceuticals & Plastics, Prostheses, medical
HQ Location
11, Rue d'édimbourg
Jumet, 6040, BE
Keywords
bone graft substitutesBone void fillersOrthopedicsReconstructive orthopedic surgeryTraumaBone tissue engineeringInjectable bone substitutesBiomaterialsand Medical Device
Location
2
- 11, Rue d'édimbourg Jumet, 6040, BE
Email Formats
Sign up for free credits and discover verified email addresses of Graftys
FormatExamples
first + last
andywarhol@graftys.com
first_initial + last
awarhol@graftys.com
first + last_initial
andyw@graftys.com
first
andy@graftys.com
last
warhol@graftys.com
Frequently Asked Questions
Key Contacts
Similar Companies
Medical Device, Pharmaceutical Manufacturing, Manufacturing Sector
Get key business info for Graftys and other 100M companies. Start your seach.
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.